CJC-1295

RESEARCH PEPTIDES · GLOSSARY ENTRY

CJC-1295

A synthetic growth-hormone-releasing hormone (GHRH) analogue — modified to extend its half-life, used to raise endogenous growth hormone secretion.

Why it matters

CJC-1295 exists in two forms: CJC-1295 without DAC (short half-life, requires multiple daily doses) and CJC-1295 with DAC (drug affinity complex, extended half-life of about a week). Both stimulate the pituitary to release growth hormone via the GHRH receptor.

In practice

Typical research use stacks CJC-1295 with a ghrelin-receptor agonist like ipamorelin for additive growth hormone release. Subcutaneous injection is the standard route.

Common confusion

“Growth hormone peptides” are sometimes treated as equivalent to exogenous growth hormone. The pharmacology is different — these compounds work upstream of GH release rather than replacing it.

RELATED TERMS
SOURCES

    This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.

    Scroll to Top

    Disclaimer: Alternative Pharm Press is an independent editorial publication and brand directory; we do not sell, manufacture, or ship any products. The statements and products referenced on this site have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Content is provided for general informational and educational purposes only and is not medical, legal, or professional advice. Always consult a licensed healthcare provider before using kratom, cannabis, CBD, hemp, nootropic, peptide, or any related product, especially if you are under 21, pregnant or nursing, taking medication, or managing a health condition. The legal status of these products varies by country, state, and locality; you are solely responsible for verifying and complying with the laws that apply to you. Some listings, reviews, and coupons may be paid placements or affiliate relationships, which do not influence our editorial standards.